{
    "id": "correct_subsidiary_00046_0",
    "rank": 88,
    "data": {
        "url": "https://www.scribd.com/document/341504810/GSK-Annual-Report-2015",
        "read_more_link": "",
        "language": "en",
        "title": "GSK Annual Report 2015",
        "top_image": "https://imgv2-1-f.scribdassets.com/img/document/341504810/original/b6ee08762a/1721601280?v=1",
        "meta_img": "https://imgv2-1-f.scribdassets.com/img/document/341504810/original/b6ee08762a/1721601280?v=1",
        "images": [
            "https://s-f.scribdassets.com/webpack/assets/images/shared/gr_table_reading.9f6101a1.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Naufal Bayu Prasetyo"
        ],
        "publish_date": null,
        "summary": "",
        "meta_description": "GSK Annual Report 2015 - Free ebook download as PDF File (.pdf), Text File (.txt) or read book online for free. In 2015, GSK made substantial progress to accelerate new product sales growth, integrate new businesses in Vaccines and Consumer Healthcare, and restructure its global Pharmaceuticals business. This progress positions the company well to return to core earnings growth in 2016. Key achievements in 2015 included increasing total turnover by 6% to Â£23.9 billion, strengthening the new product portfolio, and progressing a promising pipeline of potential new medicines and vaccines.",
        "meta_lang": "en",
        "meta_favicon": "https://s-f.scribdassets.com/scribd.ico?668e60fe0?v=5",
        "meta_site_name": "Scribd",
        "canonical_link": "https://www.scribd.com/document/341504810/GSK-Annual-Report-2015",
        "text": ""
    }
}